Principal Investigator Training
PI Certification
PI Certification
Advanced Principal Investigator Physician Certification (APIPC) Syllabus
CME Handout
Principal Investigator Toolkit
How to Effectively Use this Course
Principal Investigators Roles, Checklists, & GCP Guidelines
Principal Investigators Reporting Responsibilities for AEs and SAEs
FREE PREVIEWFDA Form 1572 - Part 1
FDA Form 1572 - Part 2
Investigator Initiated Multi-Center Trials
Investigational Product Storage and Dispensing
Investigational Product Accountability in Clinical Trials
Advanced Review of Phases of Clinical Trials (Preclinical & Phase 0-4)
Advanced Designs of Clinical Trials
Institutional Review Board/Ethics Committee (IRB/EC) (Requirements, sIRB, Application, Exemptions, Expedited Review, Continuation, and Reporting)
Randomized Controlled Trials (Randomization, Allocation Concealment, Validity, Blinding, Controls, Outcomes, Fidelity)
The Clinical Trial Protocol - Advanced Mastery Review
Protocol Deviations and Violations (Major, Minor, Exceptions, Resolution)
Inclusion and Exclusion Criteria in Clinical Research (Writing, Assessing for Broad vs. Narrow, Organ Dysfunction, Older Adults, Pediatrics, Pregnant Women)
Informed Consent (ICH GCP Section 4.8)
Trial Management, Data Handling, and Record Keeping
Compliance with E-Signatures CFR 21 Part 11
Essential Regulatory Documents Guidance and Binder Tabs
Guidelines for Designing and Completing Case Report Forms
Do’s and Don’ts of a Case Report Form Design
Investigators Brochures
Trial Master File and DIA Model
Trial Master File Reference Guide
Financial Disclosures and Conflicts of Interest
Advanced Review of Adverse Events
Types of Monitoring Visits (Selection, Initiation, Routine, Close-Out)
Site and Investigator Selection Criteria (Process, Criteria, Investigator Selection, Agreements, Decision-Making)
Site Selection/Qualification Pre-Study Visit (SSV/SQV) (Before, During, After, Letters, Checklists, and Report)
Site Initiation Visit (SIV) (Before, During, After, Letters, Checklists, and Report) - Review from "Types of Monitoring Visits"
Routine/Interim/Periodic Monitoring Visit (RMV/IMV/PMV) (Before, During, After, Remote, Letters, Checklists, and Report)
Site Close Out Visit (Before, During, After, Early Termination, Letters, Checklists, and Report)
Principal Investigator Certification
I would characterize some of the lectures as monotonous. While providing a plethora of information, instructors ought to possess an enhanced comprehension of...
Read MoreI would characterize some of the lectures as monotonous. While providing a plethora of information, instructors ought to possess an enhanced comprehension of the subject matter. This would enable them to effectively distill the essential concepts required for learning, rather than merely presenting an assortment of factual statements. By doing so, students would be able to comprehend the significance of the material, thereby enhancing their overall understanding of the topic.
Read LessThe introduction and steps to prepare for the modules, achieving success, and certification were very well developed. Excellent introduction.
The introduction and steps to prepare for the modules, achieving success, and certification were very well developed. Excellent introduction.
Read LessGood
Good
Read LessPrincipal Investigator Roles And Responsibilities In Clinical Research
Protect subject safety: Protect subjects from harm, Keep track of drugs and distribute only as specified in the protocol, Obtain informed consent, Ensure IRB approval, Keep careful records and maintain them for as long as the protocol dictates or at least 2 years AND
Report: Progress, safety, financial, and a final report to the study sponsor, Adverse events; serious adverse events must be reported immediately, Update financial disclosures if any circumstances change during the study AND
Follow Form 1572: Strictly adhere to the protocol, Directly supervise the study and take responsibility for study staff, Inform subjects of experimental nature of the drug products, Report adverse events and stay updated on the investigational brochure, Maintain records, Ensure IRB compliance AND
Prepare for FDA inspections: Ensure all records are complete and easily accessible by FDA, Send a written response within 15 business days if any violations are found AND
Avoid violations: Read all communications from the IRB, Hire experienced staff and verify their credentials, Train staff regularly, Check for conflicts of interest/financial disclosures regularly, Write efficient protocols or reduce inefficiencies or confusing portions of the protocol, Keep regulatory binders up to date and conduct continuing reviews, Meet with the team regularly, Conduct several dry runs to ensure the study will run smoothly, Regularly check data processes